Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling.

Nature methods·2025

Same author

A complex phylogeny of lineage plasticity in metastatic castration resistant prostate cancer.

NPJ precision oncology·2025

Same author

Predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer via interpretable multimodal deep learning.

NPJ digital medicine·2025

Same author

A microglia clonal inflammatory disorder in Alzheimer's disease.

eLife·2025

Same author

Role of clonal inflammatory microglia in histiocytosis-associated neurodegeneration.

Neuron·2025

Same author

Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients.

Oncotarget·2025

Search research articles

Related Experiment Video

Updated: Nov 4, 2025

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

Towards artificial intelligence-driven pathology assessment for hematological malignancies.

Olivier Elemento¹

¹Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, New York. ole2001@med.cornell.edu.

Blood Cancer Discovery

|May 24, 2021

Summary

Machine learning analyzed bone marrow images from Myelodysplastic Syndrome (MDS) patients. This approach offers new insights into MDS disease mechanisms and aids in diagnosing blood cancers.

More Related Videos

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Related Experiment Videos

Last Updated: Nov 4, 2025

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Area of Science:

Hematology
Computational Pathology
Oncology

Background:

Myelodysplastic Syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
Accurate diagnosis and understanding of MDS pathobiology are crucial for effective treatment.
Histopathology is a key diagnostic tool, but interpretation can be subjective.

Purpose of the Study:

To investigate the utility of machine learning (ML) for analyzing bone marrow histopathology images in Myelodysplastic Syndrome (MDS).
To uncover novel insights into the pathobiology of MDS using computational approaches.
To explore the potential of artificial intelligence (AI) in the diagnostic workflow for hematological malignancies.

Main Methods:

Application of unsupervised and supervised machine learning algorithms.
Analysis of digitalized bone marrow histopathology images from MDS patients.
Comparative analysis to identify patterns and features relevant to MDS subtypes and progression.

Main Results:

Machine learning models successfully identified distinct patterns in bone marrow images associated with MDS.
The study revealed new insights into the underlying pathobiology of Myelodysplastic Syndromes.
AI-driven analysis demonstrated potential for objective and quantitative assessment of histopathological features.

Conclusions:

Unsupervised and supervised machine learning are powerful tools for analyzing complex histopathology data in MDS.
This study highlights the potential of AI to enhance the accuracy and efficiency of diagnosing hematological malignancies.
The findings pave the way for integrating AI into routine clinical practice for MDS assessment and diagnosis.